US Patent

US11918693 — Ibuprofen and acetaminophen tablet

Formulation · Assigned to Haleon US Holdings LLC · Expires 2041-07-09 · 15y remaining

Vulnerability score 55/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects a novel composition and method of manufacturing large-scale, commercially viable ibuprofen and acetaminophen tablets.

USPTO Abstract

The present invention provides novel compositions, methods of treatment and methods of manufacture of large scale, commercially viable ibuprofen and acetaminophen tablets. The unique characteristics and synergistic effects resulting from the disclosed compositions, methods of treatment and methods of manufacture demonstrate a product with optimal analgesia, anti-pyresis, safety profiles and large-scale manufacturability. The inventions described herein surprisingly show the unique composition and method of manufacturing for a large-scale commercial batch of a novel ibuprofen and acetaminophen tablet.

Drugs covered by this patent

Patent Metadata

Patent number
US11918693
Jurisdiction
US
Classification
Formulation
Expires
2041-07-09
Drug substance claim
No
Drug product claim
Yes
Assignee
Haleon US Holdings LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.